Search Results - "Hada, Taira"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Clinical significance of retained products of conception in placenta previa: a retrospective analysis by Kishimoto, Naohisa, Miyamoto, Morikazu, Imauji, Akari, Takada, Minori, Nishitani, Soko, Tanabe, Risa, Ito, Tsubasa, Hada, Taira, Otsuka, Yuka, Takano, Masashi

    Published in BMC pregnancy and childbirth (30-06-2023)
    “…Retained products of conception (RPOC) often cause severe postpartum hemorrhage (PPH) but the clinical significance of RPOC in placenta previa is unclear. This…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature by Hada, Taira, Miyamoto, Morikazu, Ishibashi, Hiroki, Matsuura, Hiroko, Sakamoto, Takahiro, Kakimoto, Soichiro, Iwahashi, Hideki, Tsuda, Hitoshi, Takano, Masashi

    Published in Journal of ovarian research (14-02-2021)
    “…In ovarian mucinous carcinoma, invasive pattern is the important factor but there were less reposts to investigate it. The aim of this study was to examine the…”
    Get full text
    Journal Article
  5. 5

    Applicability of ultrasonography for detection of marginal sinus placenta previa by Ishibashi, Hiroki, Miyamoto, Morikazu, Shinmoto, Hiroshi, Soga, Shigeyoshi, Iwahashi, Hideki, Kakimoto, Soichiro, Matsuura, Hiroko, Sakamoto, Takahiro, Hada, Taira, Suzuki, Rie, Takano, Masashi

    Published in Medicine (Baltimore) (08-01-2021)
    “…This study aimed to examine whether marginal sinus placenta previa, defined as when the marginal sinus just reaches the internal cervical os and placental…”
    Get full text
    Journal Article
  6. 6

    Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma by Kakimoto, Soichiro, Miyamoto, Morikazu, Einama, Takahiro, Matsuura, Hiroko, Iwahashi, Hideki, Ishibashi, Hiroki, Sakamoto, Takahiro, Hada, Taira, Takano, Masashi

    Published in Pathology oncology research (01-10-2020)
    “…The aim of this study was to investigate the association between the clinicopathologic factors and either expression or co-expression of mesothelin and cancer…”
    Get full text
    Journal Article
  7. 7

    Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis by Hada, Taira, Miyamoto, Morikazu, Ishibashi, Hiroki, Matsuura, Hiroko, Kakimoto, Soichiro, Iwahashi, Hideki, Tsuda, Hitoshi, Takano, Masashi

    Published in Diagnostic pathology (20-01-2022)
    “…The aim of this study was to evaluate the clinicopathological factors and prognosis of mucinous carcinoma (MC) with infiltrative invasion, MC with expansile…”
    Get full text
    Journal Article
  8. 8

    Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis by Kakimoto, Soichiro, Miyamoto, Morikazu, Einama, Takahiro, Takihata, Yasuhiro, Matsuura, Hiroko, Iwahashi, Hideki, Ishibashi, Hiroki, Sakamoto, Takahiro, Hada, Taira, Suminokura, Jin, Ito, Tsubasa, Suzuki, Rie, Suzuki, Ayako, Takano, Masashi

    Published in Diagnostic pathology (08-04-2021)
    “…This study aimed to investigate the association between clinicopathologic factors, mesothelin, and cancer antigen (CA) 125 in endometrial carcinoma. Between…”
    Get full text
    Journal Article
  9. 9

    Diagnostic efficacy of ascites cell block for ovarian clear cell carcinoma by Iwahashi, Hideki, Miyamoto, Morikazu, Minabe, Shinya, Hada, Taira, Sakamoto, Takahiro, Ishibashi, Hiroki, Kakimoto, Soichiro, Matsuura, Hiroko, Suzuki, Rie, Matsukuma, Susumu, Tsuda, Hitoshi, Takano, Masashi

    Published in Diagnostic cytopathology (01-06-2021)
    “…Background Ascites cytology is important for determining the stage and treatment methods for ovarian clear cell carcinoma (CCC) as defined by the 2014…”
    Get full text
    Journal Article
  10. 10

    Placenta previa may acquire invasive nature by factors associated with epithelial‐mesenchymal transition and matrix metalloproteinases by Soyama, Hiroaki, Miyamoto, Morikazu, Ishibashi, Hiroki, Iwahashi, Hideki, Matsuura, Hiroko, Kakimoto, Soichiro, Suzuki, Rie, Sakamoto, Takahiro, Hada, Taira, Takano, Masashi

    “…Aim To investigate the differences in epithelial‐mesenchymal transition (EMT)‐ and matrix metalloproteinases (MMP)‐related factors among placenta previa with…”
    Get full text
    Journal Article
  11. 11

    Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis by Hada, Taira, Miyamoto, Morikazu, Ohtsuka, Yuka, Suminokura, Jin, Ito, Tsubasa, Kishimoto, Naohisa, Nishitani, Soko, Takada, Minori, Imauji, Akari, Tanabe, Risa, Takano, Masashi

    Published in Diagnostic pathology (20-04-2023)
    “…Mucinous carcinoma (MC) is a histological subtype of ovarian cancer that has a worse prognosis at advanced stages than the most prevalent histological subtype,…”
    Get full text
    Journal Article
  12. 12

    Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors by Hada, Taira, Miyamoto, Morikazu, Ishibashi, Hiroki, Kawauchi, Haruka, Soyama, Hiroaki, Matsuura, Hiroko, Sakamoto, Takahiro, Kakimoto, Soichiro, Aoyama, Tadashi, Iwahashi, Hideki, Suzuki, Rie, Tsuda, Hitoshi, Takano, Masashi

    Published in In vivo (Athens) (01-05-2020)
    “…To examine the clinicopathological features of ovarian seromucinous borderline tumors (SMBTs) and compare them with those of mucinous borderline/atypical…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases by Hada, Taira, Miyamoto, Morikazu, Ishibashi, Hiroki, Matsuura, Hiroko, Sakamoto, Takahiro, Kakimoto, Soichiro, Iwahashi, Hideki, Suzuki, Rie, Tsuda, Hitoshi, Takano, Masashi

    Published in Molecular and clinical oncology (01-04-2021)
    “…The aim of the present study was to examine the clinical outcome of ovarian clear cell borderline tumor (CCBT) through pathological review for cases with clear…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis by Hada, Taira, Miyamoto, Morikazu, Ishibashi, Hiroki, Matsuura, Hiroko, Sakamoto, Takahiro, Kakimoto, Soichiro, Iwahashi, Hideki, Suzuki, Rie, Sato, Kimiya, Tsuda, Hitoshi, Takano, Masashi

    Published in Medicine (Baltimore) (13-08-2021)
    “…There is a similarity of histological features and survival between ovarian mucinous carcinoma (MC) with expansile invasion and ovarian mucinous borderline…”
    Get full text
    Journal Article
  17. 17

    The use of magnetic resonance imaging to predict placenta previa with placenta accreta spectrum by Ishibashi, Hiroki, Miyamoto, Morikazu, Shinmoto, Hiroshi, Soga, Shigeyoshi, Matsuura, Hiroko, Kakimoto, Soichiro, Iwahashi, Hideki, Sakamoto, Takahiro, Hada, Taira, Suzuki, Rie, Takano, Masashi

    “…Massive hemorrhage due to placenta previa with placenta accreta spectrum is associated with high maternal mortality and morbidity. Therefore, accurate…”
    Get more information
    Journal Article
  18. 18
  19. 19

    The worsening impact of programmed cell death ligand 1 in ovarian clear cell carcinomas by Matsuura, Hiroko, Miyamoto, Morikazu, Hada, Taira, Ishibashi, Hiroki, Iwahashi, Hideki, Kakimoto, Soichiro, Suzuki, Rie, Ito, Tsubasa, Suminokura, Jin, Tsuda, Hitoshi, Takano, Masashi

    Published in Archives of gynecology and obstetrics (01-12-2022)
    “…Purpose To investigate the clinical significance of programmed cell death ligand 1 (PD-L1) expression in ovarian clear cell carcinoma (CCC). Materials and…”
    Get full text
    Journal Article
  20. 20